title: Biological and molecular basis of human breast cancer.
abstract: Human breast cancer remains the most common malignancy in the American women. The ultimate cure of this disease relies on a better understanding of the mechanisms underlying the initiation and progression of this disease. The neoplastic transformation of HBEC in vitro represents a successful model for obtaining knowledge on the molecular and biological alterations that may contribute to the tumorigenic mechanisms. We have presented here a current understanding of chemically transformed HBEC in the following aspects: 1. Factors affecting the transformation of HBEC such as genetic predisposition and differentiation status and prior immortalization; 2. New targets for studying the mechanism of cell immortalization such as alterations in telomerase activity and differential expression of cell cycle dependent genes as well as others recently isolated through differential cloning such as H-ferritin, and a calcium binding protein; 3. Epigenetic and genetic mechanisms underlying cell transformation; 4. The association of microsatellite instability in specific loci on chromosomes 11, 13, and 16 with the progression of cell transformation; and 5. The application of microcell mediated chromosome transfer technique as an approach to testing the functional role of specific genes whose dysregulation or loss of function may contribute to the ultimate cell transformation. Further efforts in this cell system will be directed to determine the roles of identified molecular changes as well as the mapping/cloning of tumor suppressor or senescence genes such as those that may reside on chromosomes 11 or 17.
authors.affiliation: Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
authors.forename: J
authors.initials: J
authors.lastname: Russo
authors.forename: X
authors.initials: X
authors.lastname: Yang
authors.forename: Y F
authors.initials: YF
authors.lastname: Hu
authors.forename: B A
authors.initials: BA
authors.lastname: Bove
authors.forename: Y
authors.initials: Y
authors.lastname: Huang
authors.forename: I D
authors.initials: ID
authors.lastname: Silva
authors.forename: Q
authors.initials: Q
authors.lastname: Tahin
authors.forename: Y
authors.initials: Y
authors.lastname: Wu
authors.forename: N
authors.initials: N
authors.lastname: Higgy
authors.forename: A
authors.initials: A
authors.lastname: Zekri
authors.forename: I H
authors.initials: IH
authors.lastname: Russo
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D002352:Carrier Proteins / Q000378:metabolism; D018929:Cell Culture Techniques; D002453:Cell Cycle / Q000235:genetics; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002478:Cells, Cultured; D002880:Chromosomes, Human, Pair 11; D002886:Chromosomes, Human, Pair 17; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology*; D000074026:Fatty Acid Binding Protein 3; D050556:Fatty Acid-Binding Proteins; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018895:Microsatellite Repeats; D019098:Telomerase / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; C493408:FABP3 protein, human; D000074026:Fatty Acid Binding Protein 3; D050556:Fatty Acid-Binding Proteins; D019098:Telomerase